含激酶插入区受体,kinase-insert domain- containing receptor英语短句,例句大全

含激酶插入区受体,kinase-insert domain- containing receptor
1)kinase-insert domain- containing receptor含激酶插入区受体
1.To explore the expression of epidermal growth factor receptor(EGFR)and kinase-insert domain- containing receptor (KDR) in gastric cancer,analyze their relationship with clinicopathological features, and discuss their clinical significance.探讨表皮生长因子受体(epidermal growth factor receptor,EGFR)和含激酶插入区受体(kinase-insert domain-containing receptor,KDR)的表达与胃癌临床病理特征的关系及其临床意义。
2)receptor-like kinases受体激酶
1.However, the study of plant receptor-like kinases (RLK.在植物和动物中，受体激酶(receptor-like kinases，RLKs)介导了各种各样的细胞信号传导途径。

英文短句/例句

1.Screening of IRTK Agonist from Traditional Chinese Medicine;中药提取物中胰岛素受体激酶激动剂的筛选
2.Isolation Characterization and Expression of cDNA Clones Encoding a G Protein-coupled Receptor Kinase of the Ascidian Ciona Intestinalis;海鞘G蛋白偶联受体激酶cDNA的克隆定性与表达
3.Expression of receptor tyrosine kinase EphA1 in gastric cancer and its clinicopathological significance受体酪氨酸激酶EphA1 mRNA在胃癌中的表达
4.Expression of protease activated receptors in mast cells蛋白酶激活受体在鼠肥大细胞的表达
5.Clinical Study of the Expression of Tissue Factor and Urokinase Plasminogen Activator Receptor in Breast Cancer组织因子、尿激酶型纤溶酶原激活剂受体在乳腺癌中的表达
6.Clinical Significance of Measurement of Plasma Urokinase Type Plasminogen Activator and its Receptor in Cancer Patients癌症患者尿激酶型纤溶酶原激活物及其受体检测的临床意义
7.The Relationship between the Expression of Yrokinase-type Plasminogen Activator Receptor,and the Infiltration and Metastasis of Gastric Cancer尿激酶型纤溶酶原激活物受体表达与胃癌浸润和转移过程的关系
8.Expression of urokinase-type plasminogen activator and its receptor protein in synovial tissues from osteoarthritis骨关节炎滑膜中尿激酶型纤溶酶原激活物及其受体蛋白的表达
9.Preparation and Characterization of Monoclonal Antibody Against Protease Activated Receptor-2;抗蛋白酶激活受体-2单克隆抗体的制备与鉴定
10.Preparation and Characterization of Monoclonal Antibody Against Protease Activated Receptor-4;抗蛋白酶激活受体-4单克隆抗体的制备与鉴定
11.CUE Domain Containing 2 (CUEDC2) Regulates Degradation of Progesterone Receptor by Ubiquitin-proteasome;CUEDC2通过泛素蛋白酶体调节孕激素受体PR的降解
12.Peroxisome proliferator activated receptors and inflammatory diseases过氧化物酶体增殖物激活受体与炎症性疾病
13.Any of various enzymes that catalyze the transfer of a phosphate group from a donor, such as ADP or ATP, to an acceptor.激酶能催化施体，例如，ADP或ATP中的磷酸酯转化给接受体的各种酶
14.Virtually Screening for Natural Pan Agonists of the Peroxisome Proliferator Actived Receptors过氧化物酶体增殖物激活受体天然泛激动剂的虚拟筛选
15.Detection of Urokinase-type Plasminogen Activator Receptor and Its Clinical Significance in Cervical Cancer;宫颈癌患者尿激酶受体的检测及其临床意义
16.Expression of Receptor Tyrosine Kinase RON in Colorectal Cancer and Its Significance;大肠癌组织中酷氨酸激酶受体RON的表达及意义
17.Study of Aromatase Cytochrome P450 and Estrogen Receptor in Adenomyosis;芳香化酶及雌激素受体与子宫腺肌病的研究
18.Detection of Urokinase-type Plasminogen Activator Receptor and its Clinical Significance in Lung Cancer;肺癌患者尿激酶受体的检测及其临床意义

相关短句/例句

receptor-like kinases受体激酶
1.However, the study of plant receptor-like kinases (RLK.在植物和动物中，受体激酶(receptor-like kinases，RLKs)介导了各种各样的细胞信号传导途径。
3)urokinase-type plasminogen activator receptor尿激酶受体
1.Objective: To find the difference between the levels of urokinase-type plasminogen activator(uPA) and urokinase-type plasminogen activator receptor(uPAR) in the seminal plasma and sperm of fertile and oligoasthenozoospermia men,and to understand their correlation with male fertility.②正常生育男性精子尿激酶受体平均含量为(12。
4)UPAR尿激酶受体
1.ATF can bind to the urokinase type plasminogen activator receptor (uPAR) with high affinity (K_d=4×10.活性测定结果表明rhATF能够阻断尿激酶原与尿激酶受体的结合,并能抑制尿激酶对纤溶酶原以及纤溶酶对尿激酶原的激活。
5)Urokinase receptor尿激酶受体
1.The effect of antisense RNA for urokinase receptor(uPAR) on inhibition of invasiveness of human lung giant cancer cell lines 95D was observed.为了观察尿激酶受体(uPAR)反义核酸对肿瘤细胞体外侵袭的抑制作用,用PCR方法扩增uPARcDNA 5′端 -4 6bp～ +45 4bp一段长 5 0 0bp的序列,利用DNA重组技术将其克隆到病毒载体pAdeno X中,构建出重组腺病毒载体pAdeno X uPAR( - )和pAdeno X uPAR( +)。
6)Receptor-like kinase (RLK)类受体激酶